Introduction
Peritoneal recurrence is a common cause of death even after curative resection for gastric adenocarcinoma [1] [2] [3] [4] [5] [6] . This is believed to be due to the presence of malignant cells that have already seeded at the time of operation but cannot be detected macroscopically. The usefulness of peritoneal washing cytology (PWC) to identify intraperitoneal free cancer cells, which have the potential for peritoneal dissemination, has been previously reported [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] .
surgeon evaluated the possibility of performing a curative resection. Physiological saline solution (100 ml) was introduced into the abdominal cavity and manually dispersed. A sample of 20-50 ml of fluid was subsequently recovered from several regions of the abdominal cavity, including the pouch of Douglas, the paracolic gutters, and the left subhepatic region. Cytological examination was done by experienced cytopathologists. The result of the cytological examination was reported 1 week after surgery because a quick and accurate assessment of the peritoneal fluid was not available in our institution. The D2 gastrectomy was carried out without knowledge of the cytological status. Standard D2 gastrectomy, according to the Japanese Research Society for Gastric Cancer, was performed. The disease was staged according to the UICC/AJCC TNM staging system. Recurrence was categorized as peritoneal, locoregional, or distant. Peritoneal recurrence was documented by positive cytology in the ascites fluid or by peritoneal nodules on radiological imaging. Recurrence involving the ovaries (Krukenberg's tumor) was considered a peritoneal recurrence.
Clinicopathological characteristics of patients with positive PWC were compared with those of patients with negative PWC. Student's t-test and the chi-squared test were used to test statistical hypotheses. Multiple logistic regression was used to identify significant and independent characteristics associated with positive PWC. Survival probabilities were estimated with the Kaplan-Meier method, and the 95% confidence intervals (CI) were estimated using Greenwood's method. The log-rank test was used to test for differences between two survival curves. Multivariable Cox regression was used to obtain a set of independent prognostic factors significantly associated with overall survival. Statistical significance was defined as P ≤ 0.05. All statistical analyses were performed using STATA version 7 (Stata, College Station, TX, USA).
Results
PWC was positive for cancer cells in 22 of 97 patients (23%) and was negative in 75 of 97 patients (77%). The median age of patients with positive PWC was 58.5 years (range 41-76 years), and 60 years (range 31-83 years) for those with negative PWC. The median follow-up period was 49 months (range 3-119 months).
Clinicopathological characteristics
The relation between the PWC result and various clinicopathological characteristics is presented in Table 1 . There were significant associations between positive PWC and more proximal tumor location, scirrhous tumor, poorly differentiated histology, presence of angiolymphatic invasion, pT3 or pT4 tumor, regional lymph node involvement, and higher TNM staging. There was no association between positive PWC and sex or between positive PWC and age.
Multiple logistic regression revealed only higher TNM staging and presence of angiolymphatic invasion to be independently associated with positive PWC (Table 2 ). There was no significant interaction between these two characteristics.
Peritoneal recurrence
At the end of this study, 54 patients (56%) remained free of disease, and 43 patients (44%) had recurrent disease. Among all of the patients, 28 (29%) had died from recurrent disease and 15 patients (15%) were still alive with recurrence. All 22 patients with positive cytology developed peritoneal recurrence. Locoregionl and distant recurrence was also seen in 10 of 22 patients (46%) and 5 of 22 patients (23%), respectively. The relation between peritoneal recurrence and PWC results is presented in Table 3 . Whereas all positive PWC patients developed peritoneal recurrence (100%), negative PWC patients developed peritoneal recurrence in only 14 of 75 patients (19%). Patients with positive PWC had a 5.4 times higher risk of peritoneal recurrence (95% CI 3.3-8.6). The sensitivity and specificity of positive cytology in predicting peritoneal recurrence in our study were 61% and 100%, respectively. The positive predictive value and the negative predictive value were 100% and 81%, respectively.
Survival
At the last follow-up, 6 of 22 patients (27%) with positive PWC were still alive with recurrence and 16 of 22 patients (73%) died from recurrent disease. Most deaths occurred within 2 years after surgery. The median survival time for patients with positive PWC was 19 months (range 4-31 months), and for patients with negative PWC this was 29 months (range 4-119 months). The overall 5-year survival rates for patients with positive PWC and negative PWC were 0% and 75% (95% CI 60%-85%), respectively. The 5-year disease-free survival rates for patients with positive PWC and negative PWC were 0% and 63% (95% CI 48%-74%), respectively.
Kaplan-Meier estimates of the survival curves for patients with positive PWC and for those with negative PWC are presented in Fig. 1 . There is a clear survival difference between the two groups of patients, with the log-rank test P < 0.001. The prognosis for patients with positive PWC is similar to that of patients with TNM stage IV disease, as can be seen when Fig. 1 is compared with Fig. 2 . Among the potential prognostic variables for both overall and disease-free survival (Table 1) , only three were significant on multivariable Cox regression: the TNM stage grouping, angiolymphatic invasion, and positive PWC (Table 4) .
Discussion
Peritoneal washing cytology for detecting intraperitoneal free cancer cells was first established by Moore et al. in 1961 [22] . For gastric carcinoma, Nakajima et al. in In the present study, seven pathological variables (including tumor location, macroscopic findings, histology, angiolymphatic invasion, depth of tumor invasion, nodal involvement, and TNM stage grouping) were significantly associated with positive PWC (Table 1) , although on multiple logistic regression only TNM stage grouping and angiolymphatic invasion remained significant (Table 2 ). PWC was not positive when tumor invasion was limited to the bowel wall (pT1 and pT2). However, when the tumor invaded the serosa (pT3) and adjacent organs (pT4), the percentages of positive PWC were 19% and 73%, respectively. Previous studies also reported that serosal invasion was associated with a higher likelihood of cytological positivity [2, 3, 13, 21, 24] . It seems that the invasion of gastric serosa is a prerequisite for transperitoneal metastasis.
All gastric cancer patients who had positive PWC in this study had regional lymph node involvement or advanced disease (stage II or more). Similarly, other reports found nodal involvement to be associated with a high incidence of positive cytology [2, 10, 25] , and a statistically significant association was found between positive cytology and advanced stage cancer [1] [2] [3] 7, 10, 25, 26] . Although some previous reports confirmed the association found in this study between poor tumor differentiation and positive PWC [3, 7] , others found no such association [17, 24] . The present study also revealed that tumors with angiolymphatic invasion had a significantly higher rate of positive PWC. This result supports the theory of peritoneal carcinomatosis, which suggests shedding of cancer cells from both the serosal surface and the lymphatic system [13] .
All patients with positive PWC in this study developed peritoneal recurrence. The specificity and positive predictive value of PWC in predicting peritoneal recurrence was high (100%), but the sensitivity was only 61%. The sensitivity of PWC was also relatively low in previous reports, ranging from 14% to 70% [1, 3, 5, 14, 26] . The relatively high false-negative rate might imply technical flaws such as incomplete sampling in the lavage process. False-positive PWC has also been recognized, with a rate of 4.5%-5.0%, probably due to the presence of reactive mesothelial cells [20, 21, 26] . To reduce the false-negative rate, several authors have introduced more sensitive methods for detecting peritoneal dissemination, including immunohistochemistry and molecular biology techniques such as reverse transcriptase-polymerase chain reaction (RT-PCR) for expressing carcinoembryonic antigen (CEA) mRNA [20, 24, [27] [28] [29] [30] or trypsinogen mRNA [31] in the peritoneal washing fluid. However, these techniques are timeconsuming, expensive, and laborious compared with conventional cytology.
In this study, positive PWC was associated with a poor prognosis, even following curative surgery, with no patient surviving more than 5 years. Multivariable Cox regression found PWC to be one of the most significant independent predictors of survival. Positive PWC as an independent predictor of survival has been previously reported by many investigators [2, 3, 6, [8] [9] [10] [11] [12] [13] [14] 24] with a mean survival time of 8.6-18.4 months [1, 7, 8, 17, 20, 24, 32] . However, the influence of positive PWC on the survival of patients with gastric cancer has not been consistent. Abe et al. in 1995 [33] reported that PWC was not an independent predictor of survival. Bonenkamp et al. in 1996 found positive PWC to be a significant predictor of poor survival [8] but not an independent predictor when pT and pN stage was taken into account.
PWC should be included as an integral part of gastric cancer staging and classification. Patients with positive PWC have essentially stage IV disease (compare Figs. 1  and 2 ) even in the absence of macroscopic peritoneal dissemination. PWC may also serve as a guide in the decision to employ controversial adjuvant treatments such as intraperitoneal chemohyperthermia [34] [35] [36] or carbon-absorbed mitomycin C [37] .
Conclusion
A total of 23% of patients undergoing D2 gastrectomy with curative intent for gastric adenocarcinoma had positive PWC. There were significant associations between positive PWC and several clinicopathological factors, including tumor location, macroscopic findings, histology, depth of tumor invasion, nodal involvement, TNM stage grouping, and angiolymphatic invasion, the latter two being the only independent characteristics on multivariable analysis. Positive PWC was confined to patients with gastric cancer invading the serosa (pT3 and pT4). Positive PWC was a significant predictor of peritoneal recurrence, with a sensitivity of 61%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 81%. Patients with positive PWC had a poor prognosis with no 5-year survival. These patients should be considered to have stage IV disease and are unlikely to benefit from D2 gastrectomy. It seems prudent to add PWC as an important component in the staging of gastric adenocarcinoma.
